289 related articles for article (PubMed ID: 36140157)
1. Current Screening Strategies for Pancreatic Cancer.
Vanek P; Urban O; Zoundjiekpon V; Falt P
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140157
[TBL] [Abstract][Full Text] [Related]
2. Current trends in the diagnosis of pancreatic cancer.
Vanek P; Eid M; Psar R; Zoundjiekpon V; Urban O; Kunovský L
Vnitr Lek; 2022; 68(6):363-370. PubMed ID: 36316197
[TBL] [Abstract][Full Text] [Related]
3. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
4. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
5. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
6. Current Approaches to Pancreatic Cancer Screening.
Chhoda A; Lu L; Clerkin BM; Risch H; Farrell JJ
Am J Pathol; 2019 Jan; 189(1):22-35. PubMed ID: 30558719
[TBL] [Abstract][Full Text] [Related]
7. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.
Morani AC; Hanafy AK; Ramani NS; Katabathina VS; Yedururi S; Dasyam AK; Prasad SR
Radiol Imaging Cancer; 2020 Mar; 2(2):e190020. PubMed ID: 33778702
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
9. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
10. Early detection of pancreatic cancer: why, who, and how to screen.
Klapman J; Malafa MP
Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195
[TBL] [Abstract][Full Text] [Related]
11. Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC).
Jacobs MF; Stoffel EM
Fam Cancer; 2024 Apr; ():. PubMed ID: 38573398
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms.
Torisu Y; Takakura K; Kinoshita Y; Tomita Y; Nakano M; Saruta M
World J Clin Oncol; 2019 Feb; 10(2):67-74. PubMed ID: 30815373
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Cancer Surveillance and Novel Strategies for Screening.
Dudley B; Brand RE
Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):13-25. PubMed ID: 34798981
[TBL] [Abstract][Full Text] [Related]
14. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma.
Reznik R; Hendifar AE; Tuli R
Front Physiol; 2014; 5():87. PubMed ID: 24624093
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Pancreatic Cancer Syndromes.
Connor AA; Gallinger S
Surg Oncol Clin N Am; 2015 Oct; 24(4):733-64. PubMed ID: 26363539
[TBL] [Abstract][Full Text] [Related]
17. The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies.
Elsayed M; Abdelrahim M
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33917380
[TBL] [Abstract][Full Text] [Related]
18. Where Do We Stand with Immunotherapy for Advanced Pancreatic Ductal Adenocarcinoma: A Synopsis of Clinical Outcomes.
Akhuba L; Tigai Z; Shek D
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551952
[TBL] [Abstract][Full Text] [Related]
19. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
20. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
